RENFLEXIS: payments to doctors
Payments that named RENFLEXIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $447K
- Providers
- 6,532
- Transactions
- 18,956
- Average per transaction
- $24
The per-transaction average — $24 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,532 providers the average total is $68, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Organon | $247,849 | 55.4% |
| Merck | $187,074 | 41.8% |
| Samsung Bioepis Co., Ltd. | $12,472 | 2.8% |